It is a disease of the peripheral nerves that control muscles (unlike the muscular dystrophies, which affect the muscles themselves).

2. 05
04
03
02
01
CMT symptoms are muscle weakness, contractures and bone
deformities, sensory loss and associated symptoms.
It is a group of heterogeneous disorders which affect the motor and
sensory peripheral nerves, resulting in muscle weakness and atrophy.
CMT types are CMT1, CMT2, CMT3, and CMT4. They are major types of
CMT associated with a large number of subtypes.
CMT types are distinguished by age of onset, inheritance pattern,
severity, and whether they are linked to defects in axon or myelin.
It is a disease of the peripheral nerves that control muscles (unlike the
muscular dystrophies, which affect the muscles themselves).
DelveInsight © 2019 | All rights reserved
Charcot Marie Tooth Disease (CMT)

3. DelveInsight © 2019 | All rights reserved
• Charcot Marie Tooth total
diagnosed prevalent population
in 7 major markets (7MM)* was
3,878 cases in 2017.
•An estimated 150,000 people
was affected in the United States.
• Among the European countries,
France had the highest CMT
diagnosed prevalent population
with 272 cases, followed by the
United Kingdom, which had CMT
diagnosed prevalent population
of 228 in 2017. Whereas Spain
had the lowest diagnosed
prevalent population of 84 in
2017.
•Japan had 73 diagnosed
prevalent cases of Charcot Marie
Tooth in 2017.
* 7MM- USA, EU-5(Germany, Spain, Italy, France and UK), Japan
CMT Epidemiology

4. DelveInsight © 2019 | All rights reserved
CMT Market Outlook
Spain accounted for the least
Charcot Marie Tooth market share
(8.62%) among the 7MM countries.
Overall, the increasing
CMT prevalence,
awareness and emerging
CMT pipeline therapies
will propel CMT market
size forward during the
forecasted period.
Despite the fact that there is no currently
approved therapies for CMT treatment
and that CMT market is entirely
dependent on off-label therapies and
procedural management, companies have
not yet shifted their focus towards this
therapeutic area.
The United States had
the highest Charcot
Marie Tooth market size
in 2017 that accounts for
approximately 47% of
the total market.

5. CMT Emerging Therapies and Companies
01
02
03
Drug- PXT3003
Company- Pharnext
DelveInsight © 2019 | All rights reserved
Drug- MD1003
Company- MedDay Pharmaceuticals
Drug- ACE-083
Company- Acceleron

6. DelveInsight © 2019 | All rights reserved
Complete Information
For complete information on
Charcot Marie Tooth (CMT) Market Insights, Epidemiology and Market Forecast - 2027
please click the link below
CLICK HERE
OR
Write Us At
info@delveinsight.com

7. DelveInsight © 2019 | All rights reserved
About DelveInsight
About
DelveInsight is a premier Business Consulting
and Market Research firm focused exclusively on
the life science segment. With a wide array of
smart end-to-end solutions, the firm helps the
global Pharmaceutical and Bio-Tech companies
formulate prudent business decisions for
improving their performances to stay ahead of
the competitors.
Mission
To provide “insights across the value chain” and
helping the organization to take a prudent
business decision through the use and analysis of
actionable market intelligence. The mission also
is to provide the most effective result and
efficient service with utmost client care for
maintaining a long-term relationship with them.
Vision
To be the most trusted market research &
business consulting firm in the world; and to
continue enable the Pharma & Bio-Tech
companies to achieve their goals with the best
strategic insight and competitive solution. The
vision also is inclusive of becoming a one-stop
solution provider for the entire gamut of drug
development process.
1 2 3

8. DelveInsight © 2019 | All rights reserved
Services by DelveInsight
Opportunity
Assessment5
Report Store6
Competitive
Analysis7
PharmDelve8
Forecasting 1
Pipeline 2
Consulting 3
Market Intelligence 4

9. DelveInsight © 2019 | All rights reserved
Contact Us
info@delveinsight.com
+91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight